Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Slofenac 75mg SR tablets
1001010C0BWAAAL
|
Slofenac | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Soap liniment methylated
1003020S0AAAAAA
|
Soap soft (Rubefacient) | Soft soap | Musculoskeletal and Joint Diseases | No data available |
|
Sodium aurothiomalate 10mg/0.5ml inj ampoules
1001030J0AAACAC
|
Sodium aurothiomalate | Sodium aurothiomalate | Musculoskeletal and Joint Diseases | No data available |
|
Sodium aurothiomalate 20mg/0.5ml inj ampoules
1001030J0AAADAD
|
Sodium aurothiomalate | Sodium aurothiomalate | Musculoskeletal and Joint Diseases | No data available |
|
Sodium hyaluronate 20mg/2ml inj pre-filled syringes
1003010U0AAAAAA
|
Hyaluronic acid sodium | Hyaluronic acid sodium | Musculoskeletal and Joint Diseases | No data available |
|
Solgar Glucosamine hydrochloride 1000mg tablets
1001050A0BLAAAI
|
Solgar (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Solpadeine Migraine Ibuprofen & Codeine tablets
1001010J0DGAAAY
|
Solpadeine (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Solpaflex tablets
1001010J0CBAAAY
|
Solpaflex (Systemic) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Sulfinpyrazone 100mg tablets
1001040P0AAAAAA
|
Sulfinpyrazone | Sulfinpyrazone | Musculoskeletal and Joint Diseases | No data available |
|
Surgam 200mg tablets
1001010T0BBAAAB
|
Surgam | Tiaprofenic acid | Musculoskeletal and Joint Diseases | No data available |
|
Surgam SA 300mg capsules
1001010T0BBADAD
|
Surgam | Tiaprofenic acid | Musculoskeletal and Joint Diseases | No data available |
|
Synflex 275mg tablets
100101070BBAAAA
|
Synflex | Naproxen sodium | Musculoskeletal and Joint Diseases | No data available |
|
Tenoxicam 20mg inj vials
100101040AAADAD
|
Tenoxicam | Tenoxicam | Musculoskeletal and Joint Diseases | No data available |
|
Tiaprofenic acid 200mg tablets
1001010T0AAABAB
|
Tiaprofenic acid | Tiaprofenic acid | Musculoskeletal and Joint Diseases | No data available |
|
Tiaprofenic acid 300mg modified-release capsules
1001010T0AAADAD
|
Tiaprofenic acid | Tiaprofenic acid | Musculoskeletal and Joint Diseases | No data available |
|
Tiger Balm Red ointment
100302000BBBMA0
|
Proprietary compound preparation BNF 1003020 | Other rubefacient and topical antirheumatic preparations | Musculoskeletal and Joint Diseases | No data available |
|
Tiger Balm White ointment
100302000BBBPA0
|
Proprietary compound preparation BNF 1003020 | Other rubefacient and topical antirheumatic preparations | Musculoskeletal and Joint Diseases | No data available |
|
Tiloket 50mg capsules
1001010L0BNACAA
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Tiloket CR 100mg capsules
1001010L0BNABAI
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Tiloket CR 200mg capsules
1001010L0BNADAJ
|
Tiloket | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Tizanidine 4mg/5ml oral liquid
1002020T0AAAEAE
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tizanidine 5mg/5ml oral suspension
1002020T0AAAKAK
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tizanidine 6mg/5ml oral suspension
1002020T0AAALAL
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tizanidine 8mg/5ml oral liquid
1002020T0AAAHAH
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tocilizumab 162mg/0.9ml inj pre-filled disposable devices
1001030W0AAAEAE
|
Tocilizumab | Tocilizumab | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.